HealthQuill Chemotherapy
The USFDA has cleared AstraZeneca’s lung cancer drug Tagrisso with chemotherapy for treatment in adult patients.
Drugs Health Pharma

AstraZeneca’s non-small lung cancer therapy gets FDA clearance

HQ Team February 17, 2024: The USFDA has cleared AstraZeneca’s Tagrisso with chemotherapy for treatment in adult patients with non-small cell lung cancer..

Read More
Anixa Biosciences, Inc., announced that its partner Cleveland Clinic has begun enrolling subjects in a treatment arm to evaluate the combination of the company's breast cancer vaccine with Merck’s Keytruda (pembrolizumab) immunotherapy.
Drugs Health Medical Pharma

GSK’s Jemperli shows promise in treating endometrial cancer

HQ Team October 30, 2023: GSK plc has announced significant findings from a phase III trial trial for Jemperli (dostarlimab), a potential treatment for.

Read More
US researchers have developed a targeted chemotherapy method that may decimate all solid tumors in animals at a laboratory, and a trial has started to test it on humans.
Drugs Health Pharma

US researchers develop novel chemotherapy cancer treatment

HQ Team August 5, 2023: US researchers have developed a targeted chemotherapy method that may decimate all solid tumors in animals at a.

Read More
Merck Group’s investigational drug Keytruda, to treat gastric cancer, has failed to meet one of its two set goals, according to a NASDAQ filing.
Drugs Health Pharma

Merck’s Keytruda experimental gastric cancer drug flops in one of set goals

HQ Team June 20, 2023: Merck Group’s investigational drug Keytruda, to treat gastric cancer, has failed to meet one of its two set.

Read More